A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer

Clinical trial NCT00452413 · COMPLETED

Trial details

NCT number: NCT00452413
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Malignant Solid Tumor

Start date: 2007-05-01
Primary completion: 2009-07-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.